306
Views
11
CrossRef citations to date
0
Altmetric
Review

Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion

, , , &
Pages 2975-2987 | Published online: 30 Nov 2015

References

  • KennedySHMilevRGiacobbePCanadian Network for Mood and Anxiety Treatments (CANMAT)Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapiesJ Affect Disord2009117S44S5319656575
  • JhanwarVGBishnoiRJJhanwarMRUtility of repetitive transcranial stimulation as an augmenting treatment method in treatment-resistant depressionIndian J Psychol Med2011331929622021964
  • RossiSHallettMRossiniPMPascual-LeoneASafety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and researchClin Neurophysiol2009120200819833552
  • TrippACBupropion, a brief history of seizure riskGen Hosp Psychiatry201032221621720302998
  • TrivediMHFavaMWisniewskiSRMedication augmentation after the failure of SSRIs for depressionN Engl J Med2006354121243125216554526
  • LamRWKennedySHGrigoriadisSCanadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. III. PharmacotherapyJ Affect Disord2009117S26S4319674794
  • DhillonSYangLPCurranMPBupropionDrugs200868565368918370448
  • DamajMICarrollFIEatonJBEnantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptorsMol Pharmacol200466367568215322260
  • ColemanCCKingBRBolden-WatsonCA placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetineClin Ther20012371040105811519769
  • CroftHSettleEJrHouserTBateySRDonahueRMAscherJAA placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertralineClin Ther199921464365810363731
  • PapakostasGINuttDJHallettLATuckerVLKrishenAFavaMResolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitorsBiol Psychiatry200660121350135516934768
  • U.S. Food and Drug AdministrationWellbutrin XL (Bupropion Hydrochloride Extended-Release Tablets)Silver Spring, MDU.S. Food and Drug Administration2011
  • ZimmermanMPosternakMAAttiullahNWhy isn’t bupropion the most frequently prescribed antidepressant?J Clin Psychiatry200566560361015889947
  • DordingCMMischoulonDPetersenTJThe pharmacologic management of SSRI-induced side effects: a survey of psychiatristsAnn Clin Psychiatry200214314314712585563
  • HorneRLFergusonJMPopeHGJrTreatment of bulimia with bupropion: a multicenter controlled trialJ Clin Psychiatry19884972622663134343
  • Vila-RodriguezFDownarJBlumbergerDMRepetitive transcranial magnetic stimulation in depression: a changing landscapePsychiatric Times201313 Available from: http://www.psychiatrictimes.com/depression/repetitive-transcranial-magnetic-stimulation-depression-changing-landscapeAccessed October 12, 2015
  • ConcaADi PauliJBerausWCombining high and low frequencies in rTMS antidepressive treatment: preliminary resultsHum Psychopharmacol200217735335612415555
  • DaskalakisZJChristensenBKFitzgeraldPBChenRTranscranial magnetic stimulation a new investigational and treatment tool in psychiatryJ Neuropsychiatry Clin Neurosci200214440641512426408
  • GeorgeMSLisanbySHSackeimHATranscranial magnetic stimulation: applications in neuropsychiatryArch Gen Psychiatry199956430031110197824
  • LooCKMcFarquharTFMitchellPBA review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depressionInt J Neuropsychopharmacol2008110113114717880752
  • MachiiKCohenDRamos-EstebanezCPascual-LeoneASafety of rTMS to non-motor cortical areas in healthy participants and patientsNeurophysiol Clin20061172455471
  • MaizeyLAllenCPDervinisMComparative incidence rates of mild adverse effects to transcranial magnetic stimulationNeurophysiol Clin20131243536544
  • WassermannEMRisk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the international workshop on the safety of repetitive transcranial magnetic stimulation, June 5–7, 1996Electroencephalogr Clin Neurophysiol199810811169474057
  • ChiramberroMLindbergNIsometsäEKähkönenSAppelbergBRepetitive transcranial magnetic stimulation induced seizures in an adolescent patient with major depression: a case reportBrain Stimulat201365830831
  • BagatiDMittalSPraharajSKSarcarMKakraMKumarPRepetitive transcranial magnetic stimulation safely administered after seizureJ ECT2012281606122343584
  • HuSHWangSSZhangMMRepetitive transcranial magnetic stimulation-induced seizure of a patient with adolescent-onset depression: a case report and literature reviewJ Int Med Res20113952039204422118010
  • HarelEVZangenARothYRetiIBrawYLevkovitzYH-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility studyWorld J Biol Psychiatry201112211912620854181
  • GómezLMoralesLTrápagaOSeizure induced by sub-threshold 10-Hz rTMS in a patient with multiple risk factorsNeurophysiol Clin2011122510571058
  • RosaMAPicarelliHTeixeiraMJRosaMOMarcolinMAAccidental seizure with repetitive transcranial magnetic stimulationJ ECT200622426526617143158
  • SakkasPTheleritisCGPsarrosCPapadimitriouGNSoldatosCRJacksonian seizure in a manic patient treated with rTMSWorld J Biol Psychiatry20089215916018428081
  • PrikrylRKucerovaHOccurrence of epileptic paroxysm during repetitive transcranial magnetic stimulation treatmentJ Psychopharmacol200519331315888504
  • BernabeuMOrientFTormosJMPascual-LeoneASeizure induced by fast repetitive transcranial magnetic stimulationNeurophysiol Clin2004115717141715
  • ConcaAKönigPHausmannATranscranial magnetic stimulation induces ‘pseudoabsence seizure’Acta Psychiatr Scand2000101324624910721875
  • WassermannECohenLFlitmanSChenRHallettMSeizures in healthy people with repeated “safe” trains of transcranial magnetic stimuliLancet199634790048258268622349
  • TharayilBSGangadharBNThirthalliJAnandLSeizure with single-pulse transcranial magnetic stimulation in a 35-year-old otherwise-healthy patient with bipolar disorderJ ECT200521318818916127313
  • FauthCMeyerBProsiegelMZihlJConradBSeizure induction and magnetic brain stimulation after strokeLancet199233987893621346431
  • HömbergVNetzJGeneralised seizures induced by transcranial magnetic stimulation of motor cortexLancet1989334867312232572937
  • KandlerRSafety of transcranial magnetic stimulationLancet199033586874694701968184
  • ObermanLMPascual-LeoneAReport of seizure induced by continuous theta burst stimulationBrain Stimul20092424624720160904
  • BrogmusKProvokation eines epileptischen Anfalls durch transkranielle Magnetstimulation-eine FalldarstellungAktuelle Neurol19982504156158
  • Pascual-LeoneAValls-SoléJBrasil-NetoJCohenLGHallettMSeizure induction and transcranial magnetic stimulationLancet199233987999971348836
  • ChervyakovAPiradovMChernikovaLCapability of navigated repeated transcranial magnetic stimulation in stroke rehabilitation (Randomized blind sham-controlled study)Journal of the Neurological Sciences20133331246247
  • WallCCroarkinPBandelLResponse to repetitive transcranial magnetic stimulation induced seizures in an adolescent patient with major depression: a case reportBrain Stimulation20147233733824629832
  • U.S. Food and Drug AdministrationMAUDE Adverse Event Reporting: Neuronetics TMS2011 3004824012-2011-00004
  • MuftiMAHoltzheimerPEIIIEpsteinCMBupropion decreases resting motor threshold: a case reportBrain stimulation20103317718020633447
  • WassermannEMVariation in the response to transcranial magnetic brain stimulation in the general populationClinical Neurophysiology200211371165117112088713
  • Pfizer-RoerigZoloft (sertraline hydrochloride)Pfizer Canada Inc2012
  • Eli Lilly and CompanyProzac (fluoxetine hydrochloride)Eli Lilly Canada Inc2008
  • GenMedPCMirtazapine Product Monograph2012
  • PfizerEffexor XR Capsules (Venlafaxine Hydrochloride) Product Monograph2013
  • Eli Lilly and CompanyCymbalta (Duloxetine) Product Monograph2012
  • EdwardsJGInmanWHWiltonLPrescription-event monitoring of 10,401 patients treated with fluvoxamineBr J Psychiatry199416433873957993416
  • Lundbeck Canada IncCelexa (Citalopram hydrobromide) Product Monograph2012
  • GlaxoSmithKline IncPaxil (Paroxetine) Product Monograph2012
  • AlperKSchwartzKAKoltsRLKhanASeizure incidence in Psychopharmacological Clinical Trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reportsBiological Psychiatry20076234535417223086
  • PreskornSFastGTricyclic antidepressant-induced seizures and plasma drug concentration1002;535160162
  • HauserWAKurlandLTThe epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967Epilepsia1975161166804401
  • JanicakPGO’ReardonJPSampsonSMTranscranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatmentJ Clin Psychiatry200869222223218232722
  • KleinjungTSteffensTLandgrebeMRepetitive transcranial magnetic stimulation for tinnitus treatment: no enhancement by the dopamine and noradrenaline reuptake inhibitor bupropionBrain stimulation201142657021511205
  • CantelloRRossiSVarrasiCSlow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trialEpilepsia200748236637417295632